Japanese Government Procurement

National Hospital Organization - Notice of Procurement (Goods & Services)HEMLIBRA for Subcutaneous Injection 90mg Qty　: 56,ULTOMIRIS for Intravenous Infusion 300mg Qty　: 70

This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.

Japanese

Publishing date May 13, 2021
Type of notice Notice of Procurement (Goods & Services)
Procurement entity National Hospital Organization - Miyazaki
Classification
0004 Medical & Pharmaceutical Products
Summay of notice ⑴ Official in charge of disbursement of the procuring entity : Hideyuki Yoshizumi, Director, National Hospital Organization, Miyakonojo Medical Center
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased,
HEMLIBRA for Subcutaneous Injection 90mg Qty : 56
ULTOMIRIS for Intravenous Infusion 300mg Qty : 70
⑷ Delivery period : From August 1, 2021 to September 30, 2022
⑸ Delivery place : National Hospital Organization, Miyakonojo Medical Center
⑹ Qualification for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
① not come under Article 5 of the Regulation concerning Contract for National Hospital Organization (NHO). Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause ;
② not come under Article 6 of the Regulation concerning Contract for NHO ;
③ have Grade A, B or C in "Sales of products" for participating in tenders by Ministry of Health, Labour and Welfare (Single qualification for every ministry and agency) in Kyushu-Okinawa Region ;
④ prove to have obtained the firstclass license for selling drugs in accordance with the Pharmaceutical Affairs Law ;
⑤ prove that they can deliver the drugs on the date and to the place specified by the Obligating Officer ;
⑥ meet the qualification requirements which the Obligating Officer may specify in accordance with Article 4 of the Regulation ;
⑺ Time-limit for tender : 5 : 00 P.M. July 5, 2021
⑻ Contact point for the notice : Teruhiko Kamenosono, Director, Accounting Division, National Hospital Organization, Miyakonojo Medical Center, 5033-1 Iwayoshi-cho Miyakonojo-shi Miyazaki-
ken, 885-0014, Japan. TEL0986-23-4111